alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit









May 30, 2018


Titan Machinery, Inc.
644 E Beaton Dr.
West Fargo, ND 58078


Attn: Mark Kalvoda
Chief Financial Officer
via electronic mail


Re: Wholesale Floor Plan Credit Facility


Dear Mr. Kalvoda,


Titan Machinery, Inc. (“Titan”) and CNH Industrial Capital America LLC (“CNHI”) are parties to that Amended and Restated Wholesale Floor Plan Credit Facility and Security Agreement dated November 13, 2007, as amended from time to time, most recently amended in a letter dated March 30, 2018 (the “Agreement”). This letter will confirm that, effective May 31, 2018, the current total wholesale floor plan credit limit for Titan is $320,000,000.00.  


Best Regards,


CNH Industrial Capital America LLC




     /s/ Mike VanVlaenderen                                      
Mike VanVlaenderen, Strategic Accounts Manager




Titan agrees to the above described amendment to the Amended and Restated Wholesale Floor Plan Credit Facility and Security Agreement dated November 13, 2007, as amended.


Titan Machinery, Inc.




     /s/ Mark Kalvoda                                                 
Mark Kalvoda, Chief Financial Officer


CNH Industrial Capital America LLC
5729 Washington Ave
Racine WI 53406
Richard Darrell TRIGG, petitioner, v. Mary Katherine JONES, et al.

No. 17-7638.

Supreme Court of the United States

April 16, 2018.

Petition for writ of certiorari to the United States Court of Appeals for the Fourth Circuit denied.
**Exhibit 31.2****CERTIFICATION**I, Dirkson R. Charles, certify that:1. I have reviewed this Quarterly Report on Form 10-Q of K&F Industries, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material factor omit to state a material fact necessary to make the statements made, in light of thecircumstances under which such statements were made, not misleading with respect to the periodcovered by this report; 3. Based on my knowledge, the financial statements, and other financial information included inthis report, fairly present in all material respects the financial condition, results ofoperations and cash flows of the registrant as of, and for, the periods presented in thisreport; 4. The registrant’s other certifying officer and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the registrant and have:(a) designed such disclosure controls and procedures, or caused such disclosure controlsand procedures to be designed under our supervision, to ensure that material informationrelating to the registrant, including its consolidated subsidiaries, is made known to usby others within those entities, particularly during the period in which this report isbeing prepared;(b) evaluated the effectiveness of the registrant’s disclosure controls and proceduresand presented in this report our conclusions about the effectiveness of the disclosurecontrols and procedures, as of the end of the period covered by this report based on suchevaluation; and(c) disclosed in this report any change in the registrant’s internal control overfinancial reporting that occurred during the registrant’s most recent fiscal quarter (theregistrant’s fourth fiscal quarter in the case of an annual report) that has materiallyaffected, or is reasonably likely to materially affect, the registrant’s internal controlover financial reporting; and5. The registrant’s other certifying officer and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’s auditors and theaudit committee of registrant’s board of directors (or persons performing the equivalentfunction):(a) All significant deficiencies and material weaknesses in the design or operation ofinternal control over financial reporting which are reasonably likely to adversely affectthe registrant’s ability to record, process, summarize and report financial information;and(b) Any fraud, whether or not material, that involves management or other employees whohave a significant role in the registrant’s internal control over financial reporting.            Date: November 11, 2005 /s/ DIRKSON R. CHARLES   Dirkson R. Charles   Executive Vice President and
<TABLE> <S> <C>

<ARTICLE>           9
<MULTIPLIER>        1,000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JUL-01-1996
<PERIOD-END>                               SEP-30-1996
<CASH>                                           6,528
<INT-BEARING-DEPOSITS>                         242,487
<FED-FUNDS-SOLD>                                 1,550
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                     22,605
<INVESTMENTS-CARRYING>                          39,703
<INVESTMENTS-MARKET>                            39,397
<LOANS>                                        274,260
<ALLOWANCE>                                      2,724
<TOTAL-ASSETS>                                 351,204
<DEPOSITS>                                     267,873
<SHORT-TERM>                                    51,060
<LIABILITIES-OTHER>                              1,381
<LONG-TERM>                                     15,580
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            20
<OTHER-SE>                                      15,290
<TOTAL-LIABILITIES-AND-EQUITY>                 351,204
<INTEREST-LOAN>                                 15,646
<INTEREST-INVEST>                                2,580
<INTEREST-OTHER>                                   121
<INTEREST-TOTAL>                                18,347
<INTEREST-DEPOSIT>                               8,609
<INTEREST-EXPENSE>                              10,639
<INTEREST-INCOME-NET>                            7,708
<LOAN-LOSSES>                                      950
<SECURITIES-GAINS>                                  49
<EXPENSE-OTHER>                                  5,182
<INCOME-PRETAX>                                  2,308
<INCOME-PRE-EXTRAORDINARY>                           0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     1,403
<EPS-PRIMARY>                                      .65
<EPS-DILUTED>                                      .65
<YIELD-ACTUAL>                                    8.77
<LOANS-NON>                                        378
<LOANS-PAST>                                        88
<LOANS-TROUBLED>                                     0<F1>
<LOANS-PROBLEM>                                      0<F1>
<ALLOWANCE-OPEN>                                 2,130
<CHARGE-OFFS>                                      410
<RECOVERIES>                                        54
<ALLOWANCE-CLOSE>                                2,724
<ALLOWANCE-DOMESTIC>                             2,140
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                            584
<FN>
<F1>Only reported at year end.
        

</TABLE>
#### Herman A. SETSER, Appellant, v. UNITED STATES of America, Appellee. Marion J. SMITH, Appellant, v. SAME.

Nos. 8807, 8808.

United States Court of Appeals District of Columbia

Argued Jan. 17, 1945.

Decided Feb. 5, 1945.

Mr. John T. Bonner, of Washington, D. C. (appointed by District Court), for appellants.

Mr. Charles B. Murray, Assistant United States Attorney, of Washington, D. C., with whom Messrs. Edward M. Curran, United States Attorney, and T. Peter Ans-berry, Assistant United States Attorney, both of Washington, D. G, were on the brief, for appellee.

Before GRONER, Chief Justice, and MILLER and ARNOLD, Associate Justices.

PER CURIAM.

A careful examination of the record discloses no reversible error, and the judgment is, therefore,

Affirmed.
In Re Oliver Vaughn DOUCE, petitioner.

No. 17-1038.

Supreme Court of the United States

March 26, 2018.

Petition for writ of mandamus and/or prohibition denied.
Order entered January 20 , 2015

In The 

## Court of Appeals **Fifth District of Texas at Dallas** No. 05 - 14 - 01162 - CV HM RUBY FUND, L.P., Appellant V. C.A. RUNDELL, JR., E T AL., Appellee s On Appeal from the 116th Judicial District Court Dallas County, Texas Trial Court Cause No. DC - 10 - 09062 

### O RDER We GRANT cross - appellants’ January 13, 2015 unopposed second motion for an extension of time to a brief. Cross

- appellants shall file their brief by FEBRUARY 13, 2015
. We caution cross

- appellants that no further extension of time will be granted absent extraordinary circumstances.
/s/ ELIZABETH LANG

- MIERS JUSTICE
Roger J. LUCAS, petitioner, v. COLORADO STATE PUBLIC DEFENDER, et al.

No. 17-833.

Supreme Court of the United States

April 16, 2018.

Petition for rehearing denied.
**CERTIFICATION PURSUANT TO**

**18 U.S.C.  SECTION 1350**

**AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Annual Report of General Gold Corporation (the “Company”) on Form 10-KSB for the period ended April 30, 2005 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, William Whittle, the President, Chief Executive Officer and Chief Financial Officer (Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer) of the Company, certify, pursuant to 18 U.S.C.  section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1)            the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)            the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Dated: December 8, 2005.

 
| /s/ William Whittle |
|---------------------|

William Whittle,

President, Chief Executive Officer and Chief Financial Officer

(Principal Executive Officer, Principal Financial Officer 

and Principal Accounting Officer)
Dorothy HARTMAN, petitioner, v. BANK OF NEW YORK MELLON, et al.

No. 16-5827.

Supreme Court of the United States

Nov. 7, 2016.

Motion of petitioner for leave to proceed *in forma pauperis* denied. Petitioner allowed until November 28, 2016, within which to pay the docketing fee required by Rule 38(a) and to submit a petition in compliance with Rule 33.1 of the Rules of this Court.
# C_2013026EN.01000202.xml

| 26.1.2013 | EN | Official Journal of the European Union | C 26/2 |
| --- | --- | --- | --- |

26.1.2013

EN

Official Journal of the European Union

C 26/2

---

Judgment of the Court (Third Chamber) of 22 November 2012 — Usha Martin Ltd v Council of the European Union, European Commission

(Case C-552/10 P) (1)

1

(Appeal - Dumping - Regulation (EC) No 121/2006 - Imports of steel ropes and cables originating, inter alia, in India - Decision 2006/38/EC - Regulation (EC) No 384/96 - Article 8(9) - Undertakings offered in connection with anti-dumping proceedings)

2013/C 26/03

Language of the case: English

Parties

Parties

Appellant: Usha Martin Ltd (represented by: V. Akritidis and E. Petritsi, dikigoroï, and by F. Crespo, avocat)

Appellant:

Other parties to the proceedings: Council of the European Union (represented by: B. Driessen, acting as Agent, G. Berrisch, Rechtsanwalt, and N. Chesaites, Barrister), European Commission (represented by T. Scharf and S. Thomas, acting as Agents)

Other parties to the proceedings:

Re:

Re:

Appeal brought against the judgment of the General Court (Fifth Chamber) of 9 September 2010 in Case T-119/06: Usha Martin Ltd v Council of the European Union and European Commission in which the General Court dismissed an action, on the one hand, for annulment of Commission Decision of 22 December 2005 amending Commission Decision 1999/572/EC accepting undertakings in connection with the anti-dumping proceedings concerning imports of steel wire rope and cables originating in, inter alia, India (OJ 2006 L 22, p. 54) and, on the other hand, for annulment of Council Regulation (EC) No 121/2006 amending Council Regulation (EC) No 1858/2005 imposing a definitive anti-dumping duty on imports of steel ropes and cables originating in, inter alia, India (OJ 2006 L 22, p. 1)

Usha Martin Ltd

Council of the European Union and European Commission

Operative part of the judgment

Operative part of the judgment

The Court:

| 1. | Dismisses the appeal; |
| --- | --- |

1.

Dismisses the appeal;

| 2. | Orders Usha Martin Ltd to pay the costs of the appeal proceedings. |
| --- | --- |

2.

Orders Usha Martin Ltd to pay the costs of the appeal proceedings.

---

(1)  OJ C 55, 19.2.2011.

1

---
II-00122

From:

Sent:

To:

Subject:

Diane Timmins <dlt.nl @juno.com>

Sunday, December 5, 2010 2:15 AM

dfadefinitions <dfadefinitions@CFTC.gov>

Re: No loopholes in Dodd-Frank

1) Securities and Exchange Commission/Commodities Futures Trading Commission, Re: Commercial Risk (CFTC RIN

3235-AK65, SEC File Number $7-12-10)

Dear Commissioners Shapiro and Gensler: Don’t let the American Bankers Association (ABA) redefine important terms like

"commercial risk" to keep banks that engage in risky derivatives trading from complying with transparency and business

conduct requirements. Commercial risk should not be expanded to include financial risk. Accepting the ABA argument

would open the door for exemptions for risky hedge funds and insurance companies.

2) Commodities Futures Trading Commission, Re: Position Limits (RIN 3038-AD 17 )

Dear Commissioner Gensler: The CFTC needs to set strong position limits to crack down on the energy and food commodity

speculation that serves no productive purpose. I urge the Commission to define limits that will address not only manipulation,

but also excessive speculation, which will require a stricter approach.

3) U.S. Department of the Treasury, Re: FX Swaps (75 FR 66426 Document Number 2010-27274)

Dear Secretary Geithner: Just say "no" to foreign exchange traders who want to exempt foreign currency derivatives from the

clearing and transparency requirements of the

Dodd-Frank Act. $4 trillion dollars a day is traded in these highly-leveraged swaps and this number may increase to over $10

trillion in a decade. As the head of the Financial

Stability Oversight Board your job is to decrease risk in the system, not encourage off-book trading and opaque markets.

Diane Timmins

526 Pinyon Ct.

Longwood, FL 32750
IN THE SUPREME COURT OF PENNSYLVANIA

WESTERN DISTRICT

**EARL KENNEDY, ELIZABETH KENNEDY, CHARLES G. ELY, II, JAMES**  **SISLEY, JOANNA STORER, JOHN O.**
**HARKER, AND THE EARL KENNEDY TRUST,** 

**Petitioners**

**v.**

**CONSOL ENERGY, INC., A DELAWARE**

**CORPORATION AND CNX GAS COMPANY, LLC, A VIRGINIA LIMITED**  **LIABILITY COMPANY,**

**Respondents :** 

**:**

**:**

**:**

**:**

**:**

**:**

**:**

**:**

**:**

**:**

**:**

**:**

**:**

**:**

**:**

**:**

**: No. 197 WAL 2015** 

**Petition for Allowance of Appeal from the Order of the Superior Court** 

ORDER

PER CURIAM

AND NOW **, this 31st day of December, 2015, the Petition for Al lowance of** 

**Appeal is** DENIED

**.**

**Mr. Justice Eakin did not participate in the decision of t his matter.**
Exhibit













June 1, 2018




Dear Angelique,  


I am pleased to offer you the position of Executive Vice President, Operations at HealthEquity, Inc. (hereinafter referred to as “the Company”) upon the following terms and conditions:


DATE OF COMMENCEMENT
Your start date will be April 13, 2018.   This offer is contingent upon completion of a successful background and credit check, and the execution of an agreement between you and the Company containing non-solicitation, and non-disclosure provisions.


COMPENSATION PACKAGE
Your salary will be equivalent to $250,000.00 per year and will be paid twice monthly on the 15th and last day of every month, equating to 24 pay periods per calendar year.  


As the Executive Vice President, Operations, you will participate in the Company Executive Bonus Plan, where 50% of your base pay will be tied to individual, team and company goals.  In determining the amount of bonus pay, the Company shall consider your work performance,  and the Company meeting corporate-wide goals. Bonuses are not a guarantee and must be approved by the Compensation Committee of the Board of Directors of the Company.   Further details of this bonus policy are covered in the Executive Bonus Plan document attached hereto.


In addition to your regular salary and potential bonus, you will also be granted $167,000.00 of Performance Restricted Stock Units. These PRSU’s are subject to final approval by the Board of Directors of HealthEquity, Inc. Further details of the performance restricted stock unit equity will be provided to you separately.


Upon acceptance of this position as Executive Vice President, Operations you will be considered a Covered Person and required to comply with the provisions of the HQY Insider Trading Policy, a copy of which is attached to this letter.




 “AT WILL” EMPLOYMENT
Your employment with the Company is “at will”, which means that either you or the Company may terminate the relationship at any time.  As such, neither this letter nor any other oral or written representations may be considered a contract for any specific period of time.  


Should you have any questions, feel free to contact me at (801)727-1274.


Kindly indicate your understanding and acceptance of this offer letter by signing below and returning a copy of the entire document to the People Department.  


We look forward to having you continue your association with HealthEquity, Inc. and anticipate a long and successful future together.  


Sincerely, 




Natalie Atwood
VP, People
HealthEquity, Inc.




ACCEPTANCE OF POSITION:


By signing this offer letter, I, Angelique Hill, accept the job offer of Executive Vice President, Operations, at HealthEquity, Inc.  






__________________________________________               ____________
Signature                                                                                    Date














































Exhibit A
The Team Member Confidentiality and Non-Competition Agreement 
(see attached)

Exhibit B
HQY Insider Trading Policy 
(see attached)
Larry W. KELLY, Jr., petitioner, v. UNITED STATES.

No. 17-7934.

Supreme Court of the United States

April 2, 2018.

Petition for writ of certiorari to the United States Court of Appeals for the Fifth Circuit denied.
Arika MATELYAN, petitioner, v. ASCAP, et al.

No. 17-6335.

Supreme Court of the United States

March 19, 2018.

Petition for rehearing denied.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute on Drug Abuse Special Emphasis Panel, “NIDA's Science Meetings Logistical Support Contract”.                    

*Date:*                         July 12-13, 2001.                    

*Time:*                         9 am to 5 pm.                    

*Agenda:*                         To review and evaluate contract proposals.                    

*Place:*                         Double Tree Hotel, 1750 Rockville Pike, Rockville, MD 20852.                    

*Contact Person:*                         Lyle Furr, Contract Review Specialist, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 435-1439.                    

This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug Abuse Scientist Development Award for Clinicians, Scientist Development Awards, and Research Scientist Awards; 93.278, Drug Abuse National Research Service Awards for Research Training; 93.279, Drug Abuse Research Programs, National Institutes of Health, HHS)

Dated: June 22, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 01-16340  Filed 6-28-01; 8:45 am]

BILLING CODE 4140-01-M
Dennis Anthony NELSON, petitioner, v. UNITED STATES.

No. 15-9566.

Supreme Court of the United States

Oct. 3, 2016.

Petition for writ of certiorari to the United States Court of Appeals for the Eleventh Circuit denied.